Insurtech disruptor Oscar Health has a new vision for 2021

By William Girling
Oscar Health has officially announced that it has filed for an IPO, placing it in the ranks of other insurtech disruptors like Lemonade, Root and Hippo...

This update comes less than two months after Oscar floated the idea by issuing a draft registration statement for its proposal.

According to the company itself, Oscar intends to list its Class A common stock on the NYSE (ticker symbol ‘OSCR’). The IPO will also feature an impressive rostrum of bookrunners, including Goldman Sachs, Morgan Stanley and Allen & Company. So far there is no indication as to what the company’s IPO goal will be.

Starting the year strong

The end of 2020 saw Oscar net an impressive range of results:

CEO and Co-Founder Mario Schlosser, who founded the company in 2012 following his own poor experiences with US health insurance, stated that this all pointed towards Oscar expanding its mission nationwide:

“Since 2017, Oscar has seen annualised membership growth of more than 70%. As we continue to rapidly scale our business, [the $140m funding] will help us deliver on our commitment to bring accessible and affordable care to even more Oscar members across the country.”

Setting out a new vision for health insurance

The IPO seems to form part of an ongoing vision, which may also be contributed to by two new “strategic hires”: Alessa Quane to Chief Insurance Officer and Sameer Amin as Chief Medical Officer - both effective from March. 

“Alessa and Sameer are joining Oscar at an exciting time as we continue to expand our footprint and product offerings, including the launch of Oscar’s Virtual Primary Care in 2021,” stated Schlosser. 

“Their expertise will help us build upon the strength of our existing insurance and clinical experiences and further our ambition of making our members feel like having Oscar is like having a doctor in the family.”

Image source: Oscar


Featured Articles

Insurtech unicorn bolttech takes on extra $50m in funding

Insurtech unicorn bolttech has taken on an extra US$50m in funding from Leapfrog Investments as part of the insurtech's Series B extension

Allianz wants to 'lead by example' with new net-zero targets

Allianz has said it wants to "lead by example" after announcing ambitious new targets to make its investment and underwriting portfolios net zero

Insurtech pricing solution Akur8 seals $25m in fresh funding

Akur8, whose insurtech solution is used by actuaries to build pricing models across all insurance lines, has received backing from Guidewire and FinTLV

Beazley launches tornado parametric insurance using NWS data


Alex Dalyac: Founding AI-based insurtech Tractable

Technology & AI

Saudi Arabia: 'solid' framework to guide insurtech sector